Company Filing History:
Years Active: 2024-2025
Title: Innovations by Gregers Rom Andersen
Introduction
Gregers Rom Andersen is a notable inventor based in Brabrand, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target human complement factors. With a total of three patents to his name, Andersen's work is paving the way for advancements in medical treatments.
Latest Patents
Andersen's latest patents include innovative approaches to modulating the activity of the complement system. One of his patents, titled "Bispecific constructs for target and complement engagement," focuses on single domain antibodies that specifically bind to human complement factors such as C1q, C3, C4, and their proteolytic derivatives. This invention has potential applications in treating disorders associated with complement activation. Another patent, "Methods of treating complement-mediated disease," also involves single domain antibodies that target similar complement factors, further emphasizing Andersen's commitment to addressing complement-related health issues.
Career Highlights
Gregers Rom Andersen is affiliated with Aarhus Universitet, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to the understanding of the complement system and its implications in various diseases.
Collaborations
Andersen collaborates with esteemed colleagues such as Nick Stub Laursen and Dennis Vestergaard Pedersen. These partnerships enhance the research efforts and broaden the impact of their collective work in the field.
Conclusion
Gregers Rom Andersen's contributions to biotechnology through his patents and research at Aarhus Universitet highlight his role as an influential inventor. His work on antibodies targeting the complement system is poised to make a significant impact on medical treatments for complement-mediated diseases.